Global

Infectious Diseases Experts

Seiji Yokoyama


Medicine
Thermo Fisher
Japan

Biography

Scientific Manager: Immunodiagnostics Division: Marketing for Autoimmune diseases Company NameThermo Fisher Scientific Dates EmployedJul 2014 – Present   Employment Duration3 yrs 6 mos LocationTokyo/ Japan  Maximize the clinical value of immunodiagnostic products through collaborative researches with KOLs.  Prepare the study protocols for the collaborative researches.  Manage KOLs relationships by initiating collaborative researches, setting up the seminars for clinicians, and obtaining the supervision for the promotional materials.   Find the seeds or novel ideas of new product-development for unmet medical needs through the discussion with KOLs, and analyze the market values of those new products in cooperation with the global marketing team.  Provide the medical and scientific advices for the inquiries from the clinicians and clinical laboratorial technologists about the features of the products.  Educate the medical representatives by giving the several training.       Senior Technical Service Scientist Company NameQIAGEN Dates EmployedMay 2013 – Jun 2014   Employment Duration1 yr 2 mos  Providing technical advice and support to customers.   Communicating with global technical support teams to maintain and strengthen relationships with key account users.   Specially Appointed Assistant Professor at Medical Mycology Research Center Company NameChiba University Dates EmployedAug 2012 – May 2013   Employment Duration10 mos  Establishment of novel therapeutic modality for autoimmune diseases and fungal infections.   Resercher Company NameTokyo Metropolitan Institute of Medical Science Dates EmployedApr 2009 – Jul 2012   Employment Duration3 yrs 4 mos LocationSetagaya-ku, Tokyo, Japan  Establishment of novel therapeutic modality for Autolymphoproliferative syndrome (ALPS) by blockade of cytokine signaling with Tafacitinib (Jak kinase inhibitor)  Establishment of Antibody-based therapeutic modality of Celiac disease by using enterocytes specific human IL-15 Transgenic mice  Development of HIV vaccine with recombinant vaccinia virus expressing HIV Env, Gag, Pol and human IL-15 in mice model.

Research Interest

Medicine and Pharmaceuticals 

Global Experts from Japan

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America